Multidisciplinary Management of Advanced Mucinous Adenocarcinoma of the Lung: A Case Report

Basavalinga Sadasivaiah Ajaikumar, Shivakumar Swamy S, Roshni Dasgupta, Mithua Ghosh, Veena Ramaswamy, Lakshmipriya Kumar* and Priyank Tripathi

Executive Chairman, HealthCare Global (HCG) Enterprises Ltd, Bengaluru, India Head & Director of Radiology, Program Director, Fellowship in Oncoimaging, HCG Cancer Centre, Bengaluru, India Department of Medical Oncology, HCG Cancer Centre, Bengaluru, India Director Research and Development, Triesta Sciences (A Unit of HealthCare Global Enterprises Ltd), Bengaluru, India Clinical Director of Pathology, Triesta Sciences (A Unit of HealthCare Global Enterprises Ltd), Bengaluru, India Chief Scientific Officer–Corporate Research, HealthCare Global (HCG) Enterprises Ltd, Bengaluru, India Department of Clinical Pharmacology, HealthCare Global (HCG) Enterprises Ltd, Bengaluru, India

^*Correspondance to: Lakshmipriya Kumar 

 PDF  Full Text Case Report | Open Access

Abstract:

Managing advanced mucinous adenocarcinoma of the lung poses significant challenges, especially in patients lacking biomarkers for targeted therapies. This case illustrates the effectiveness of a multidisciplinary approach that integrates chemotherapy, immunotherapy, radiotherapy, and personalized treatment adjustments, leading to meaningful clinical responses in a patient with progressive disease.

Keywords:

Mucinous adenocarcinoma of lungs, Double immunotherapy, Next generation sequencing, Multidisciplinary team

Cite the Article:

Ajaikumar BS, Shivakumar Swamy S, Dasgupta R, Ghosh M, Ramaswamy V, Kumar L, et al. Multidisciplinary Management of Advanced Mucinous Adenocarcinoma of the Lung: A Case Report. Ann Clin Case Rep. 2025; 10: 2728..